Elite Pharmaceuticals Inc /NV/ SEC filings ELTP
Elite Pharmaceuticals Inc /NV/ has 1,000 filings in SEC EDGAR's recent list, going back to Apr 5, 2005. Its latest annual report, Form 10-K, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Feb 13, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | Feb 14, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | Feb 14, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | Feb 16, 2021 | Dec 31, 2020 |
| 10-Q | Quarterly report | Nov 16, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Feb 10, 2020 | Dec 31, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | Feb 11, 2019 | Dec 31, 2018 |
| 10-Q | Quarterly report | Nov 9, 2018 | Sep 30, 2018 |
| 10-Q/A | Amended quarterly report | Oct 17, 2018 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | Feb 9, 2018 | Dec 31, 2017 |
| 10-Q | Quarterly report | Nov 9, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 9, 2017 | Jun 30, 2017 |
| 10-Q | Quarterly report | Feb 9, 2017 | Dec 31, 2016 |
| 10-Q/A | Amended quarterly report | Nov 17, 2016 | Sep 30, 2012 |
| 10-Q | Quarterly report | Nov 9, 2016 | Sep 30, 2016 |
| 10-Q | Quarterly report | Aug 9, 2016 | Jun 30, 2016 |
| 10-Q | Quarterly report | Feb 9, 2016 | Dec 31, 2015 |
| 10-Q/A | Amended quarterly report | Dec 30, 2015 | Sep 30, 2015 |
| 10-Q/A | Amended quarterly report | Dec 30, 2015 | Jun 30, 2015 |
| 10-Q/A | Amended quarterly report | Nov 10, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Nov 9, 2015 | Sep 30, 2015 |
| 10-Q | Quarterly report | Aug 10, 2015 | Jun 30, 2015 |
| 10-Q | Quarterly report | Feb 17, 2015 | Dec 31, 2014 |
| 10-Q | Quarterly report | Nov 14, 2014 | Sep 30, 2014 |
| 10-Q | Quarterly report | Aug 14, 2014 | Jun 30, 2014 |
| 10-Q/A | Amended quarterly report | Apr 25, 2014 | Sep 30, 2013 |
| 10-Q | Quarterly report | Feb 14, 2014 | Dec 31, 2013 |
| 10-Q | Quarterly report | Nov 14, 2013 | Sep 30, 2013 |
| 10-Q | Quarterly report | Aug 14, 2013 | Jun 30, 2013 |
| 10-Q | Quarterly report | Feb 14, 2013 | Dec 31, 2012 |
| 10-Q | Quarterly report | Nov 14, 2012 | Sep 30, 2012 |
| 10-Q | Quarterly report | Aug 14, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | Feb 14, 2012 | Dec 31, 2011 |
| 10-Q | Quarterly report | Nov 14, 2011 | Sep 30, 2011 |
| 10-Q/A | Amended quarterly report | Aug 19, 2011 | Jun 30, 2011 |
| 10-Q | Quarterly report | Aug 15, 2011 | Jun 30, 2011 |
| 10-Q/A | Amended quarterly report | Apr 26, 2011 | Sep 30, 2010 |
| 10-Q | Quarterly report | Feb 14, 2011 | Dec 31, 2010 |
| 10-Q | Quarterly report | Nov 15, 2010 | Sep 30, 2010 |
| 10-Q | Quarterly report | Aug 16, 2010 | Jun 30, 2010 |
| 10-Q | Quarterly report | Feb 12, 2010 | Dec 31, 2009 |
| 10-Q | Quarterly report | Nov 16, 2009 | Sep 30, 2009 |
| 10-Q | Quarterly report | Aug 19, 2009 | Jun 30, 2009 |
| 10-Q/A | Amended quarterly report | Mar 2, 2009 | Dec 31, 2008 |
| 10-Q | Quarterly report | Feb 17, 2009 | Dec 31, 2008 |
| 10-Q | Quarterly report | Nov 14, 2008 | Sep 30, 2008 |
| 10-Q | Quarterly report | Aug 12, 2008 | Jun 30, 2008 |
| 10-Q | Quarterly report | Feb 14, 2008 | Dec 31, 2007 |
| 10-Q | Quarterly report | Nov 14, 2007 | Sep 30, 2007 |
| 10-Q | Quarterly report | Aug 10, 2007 | Jun 30, 2007 |
| 10-Q | Quarterly report | Feb 14, 2007 | Dec 31, 2006 |
| 10-Q | Quarterly report | Nov 14, 2006 | Sep 30, 2006 |
| 10-Q | Quarterly report | Aug 11, 2006 | Jun 30, 2006 |
| 10-Q | Quarterly report | Feb 14, 2006 | Dec 31, 2005 |
| 10-Q | Quarterly report | Nov 14, 2005 | Sep 30, 2005 |
| 10-Q | Quarterly report | Aug 15, 2005 | Jun 30, 2005 |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTP (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NJ
- Headquarters
- Northvale, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1053369
- Former names
- ELITE PHARMACEUTICALS INC /DE/ (until Feb 8, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.